In biotechnology, where progress depends on navigating uncertainty, leadership is tested not by smooth success but by how one responds to volatility. For Leen Kawas—scientist, entrepreneur, and CEO of EIT Pharma—resilience and adaptability are not just leadership traits; they are strategic imperatives. Her career, spanning scientific discovery, public-company leadership, and venture investment, has taught her that the most effective leaders are those who evolve without losing their center.

Leen Kawas has spent her professional life balancing two worlds: the rigor of science and the unpredictability of entrepreneurship. As the co-founder and former CEO of Athira Pharma, she led the company from an early-stage idea to a successful IPO, raising more than $400 million and advancing treatments for neurodegenerative diseases. Now, through Propel Bio Partners and her role on the board of Inherent Biosciences, she helps guide other life science founders through similar challenges. Across these experiences, her philosophy has remained constant: resilience keeps you standing; adaptability keeps you growing.

The Science of Resilience

Kawas approaches leadership like a scientist—curious, data-driven, and willing to experiment. She often describes resilience not as endurance, but as recovery: the ability to absorb change, learn quickly, and re-emerge stronger. In an industry defined by long timelines, regulatory hurdles, and unpredictable results, she sees resilience as the foundation of sustainability.

Her scientific training informs this perspective. Every experiment, she notes, teaches something—even failure. The same principle applies to leadership. “In biotech, setbacks aren’t signs of weakness; they’re data points,” she has said in interviews. “What matters is how you analyze them.” This mindset transforms adversity into insight. It reframes pressure as part of the process rather than a threat to it.

Adaptability as a Leadership Muscle

For Kawas, adaptability is the active counterpart to resilience. It is not merely about surviving change, but about anticipating and shaping it. She believes leaders must develop a kind of “strategic elasticity”—the ability to adjust direction without losing clarity of purpose.

Her own career offers proof of this principle. Moving from scientific research into executive leadership, and later into venture capital, required her to recalibrate constantly: from molecules to markets, from experiments to earnings calls, from managing teams to mentoring founders. Each transition demanded a new skill set, but the same mindset—a commitment to growth through change.

At Propel Bio Partners, she applies this philosophy to how she evaluates founders. She looks for adaptability not just in product strategy, but in temperament. “The best leaders,” she often explains, “don’t cling to one version of success. They redefine it as they learn.” In her view, adaptability fuels innovation because it keeps people open to discovery—even when that discovery challenges their assumptions.

Leading With Emotional Intelligence

Kawas believes resilience and adaptability are deeply tied to emotional intelligence. Technical skill can launch a company, but emotional awareness sustains it. Leaders who stay grounded in empathy, she says, can pivot without losing trust. They can inspire teams through uncertainty and maintain alignment even when strategies shift.

Her leadership style combines clarity with compassion. She prioritizes transparent communication—acknowledging challenges honestly while keeping teams focused on solutions. This balance builds credibility, especially in moments of turbulence. Employees, she notes, don’t expect perfection; they expect authenticity. When leaders model calm and curiosity instead of fear, they create cultures capable of adapting together.

The Power of Reflection and Renewal

For Leen Kawas, resilience is as much about reflection as it is about perseverance. She encourages leaders to pause, assess, and realign rather than pushing forward blindly. Burnout, she warns, is the enemy of adaptability; exhausted teams can’t innovate.

Her approach draws from both science and personal growth. Just as biological systems depend on feedback loops, she believes organizations thrive when leaders create space for honest feedback and self-assessment. Renewal, whether through rest, mentorship, or learning, strengthens the adaptive capacity of both individuals and institutions.

Turning Setbacks Into Strength

Few leaders understand the weight of public scrutiny as acutely as Kawas. Her time at Athira Pharma included not only triumphs but also challenges that tested her resilience. Rather than retreating, she used those experiences to refine her perspective on leadership. She has spoken about the importance of humility—of acknowledging mistakes, owning outcomes, and finding meaning in the lessons they offer.

This capacity to transform challenge into growth is what defines adaptive leadership in her view. It’s not about avoiding pressure, but learning to work with it. “In science and in life,” she once remarked, “stress is what builds strength. The key is learning to channel it.”

A Model for the Next Generation

Through her work at Propel Bio Partners, EIT Pharma, and Inherent Biosciences, Kawas mentors a new generation of biotech founders navigating the same complexities she once faced. She urges them to cultivate resilience not through bravado, but through preparation—to know their data, understand their people, and stay open to evolution. Her mentorship focuses on building both competence and confidence, reminding leaders that adaptability is a discipline, not a reaction.

In an industry where the path from idea to impact can span decades, Kawas’s message resonates widely. Resilient, adaptive leadership, she argues, is not just good management—it’s a moral responsibility. The stakes in biotechnology are human lives, and the leaders guiding innovation must be able to endure uncertainty with integrity and grace.

Leadership That Evolves With Purpose

Leen Kawas’s belief in resilient, adaptive leadership reflects a rare blend of scientific precision and human understanding. Her career stands as evidence that agility and steadiness are not opposites—they are partners. Resilience keeps leaders rooted in purpose; adaptability keeps them responsive to change. Together, they define a kind of leadership that doesn’t just survive disruption, but transforms it into progress.

In her words and her work, Kawas offers a quiet but powerful model for leadership in the life sciences and beyond: evolve continually, lead transparently, and never lose sight of the mission that makes the effort worthwhile.

Learn more about Leen Kawas in this interview on billionsuccess.com.